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Abstract: A series of phosphanes with imidazolyl substituents were prepared as hemilabile PN 
ligands. The corresponding gold(I) complexes were tested as bifunctional catalysts in the 
Markovnikov hydration of 1-octyne as well as in the synthesis of propargylamines by the three 
component coupling reaction of piperidine, benzaldehyde and phenylacetylene. While the activity in 
the hydration of 1-octyne was low, the complexes are potent catalysts for the three component 
coupling reaction. In homogenous solution the conversions to the respective propargylamine were 
considerably higher than under aqueous biphasic conditions. The connectivity of the imidazolyl 
substituents to the phosphorous atom, their substitution pattern as well as the number of 
heteroaromatic substituents have pronounced effects on the catalytic activity of the corresponding 
gold(I) complexes. Furthermore, formation of polymetallic species with Au2, Au3 and Au4 units has 
been observed and the solid-state structures of the compounds [(5)2Au3Cl2]Cl and [(3c)2Au4Cl2]Cl2 
(3c = tris(2-isopropylimidazol-4(5)-yl phosphane, 5 = 2-tert-butylimidazol-4(5)-yldiphenyl 
phosphane) were determined. The gold(I) complexes of imidazol-2-yl phosphane ligands proved to 
be a novel source for bis(NHC)gold(I) complexes (NHC = N-heterocyclic carbene). 
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For a long time, gold has been regarded as inactive as a catalytic metal due to its “chemical 
inertness”. However, recent work on the high catalytic activity of gold compounds in heterogeneous 
and homogenous catalysis proved the opposite.1 Gold catalyzed C–C coupling reactions provide 
excellent methods for the construction of complex molecules under mild conditions.2 First, salt like 
gold compounds as AuCl3 or HAuCl4 were used as catalysts followed by gold complexes bearing 
phosphane ligands.3 
Pyridylphosphanes are well-established PN ligands in transition metal chemistry.4 Imidazole-
based phosphane ligands are, however, less studied. The soft phosphorus and harder nitrogen atoms 
of those ligands make them potentially hemilabile5 and bifunctional.6 A variety of reactions 
including C–C bond formation7, carbonylation of amines8, asymmetric aldol reactions9 and 
hydration of terminal alkynes10 have been reported using gold(I) catalysts with bifunctional PN 
ligands. An interesting reaction is the C–C bond formation in the multicomponent coupling reaction 
of an aldehyde, amine and alkyne to the respective propargylamine. One-pot multicomponent 
coupling reactions are efficient methods for the preparation of complex molecules starting from 
readily available materials.  
The synthesis of propargylamines has attracted considerable attention over the last few years due 
to their pharmaceutical relevance and their importance as building blocks in the preparation of 
nitrogen-containing molecules, and as key intermediates for natural product synthesis.11 For these 
syntheses, besides gold(I) and gold(III) compounds12 iron13 and indium14 salts have been employed 
as catalysts.12 The functionalization of hydrocarbons is another important area for catalytic 
transformations. Here the hydration of terminal alkynes to the respective ketones (Markovnikov 
product) or aldehydes (anti-Markovnikov product) is of particular interest. Gold(I) species have 
started to replace gold(III) complexes15, since Teles et al. showed that complexes of the general 
composition [(L)Au]+ – with L being a phosphane, arsane or phosphite ligand – are very good 
catalysts for the addition of alcohols to alkynes, if an acid co-catalyst is present.16 In the last few 
years gold(I)-NHC (N-heterocyclic carbene) complexes17 have started to gain immense interest and 
many catalytic active gold(I)-species concerning the hydration of alkynes have been described.18 
Nonetheless there are several recent examples of gold(I)-phosphane complexes19 including gold(I) 
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complexes with bifunctional pyridylphosphane ligands, which readily convert 1-pentyne to 2-
pentanone.20  
In this work we describe the synthesis and structural properties of novel gold(I) complexes, 
containing bifunctional imidazolylphosphanes. The new compounds were tested for their application 
as catalysts in the synthesis of propargylamines and the hydration of terminal alkynes. Based on the 
results in the catalytic trials, we report different pathways for potential deactivation of the (L)AuCl 
catalysts. 
Results and Discussion 
In this work we used different homologous series of polydentate imidazolylphosphanes (Figure 1) 
and investigated their application as ligands in gold(I) catalyzed reactions.  
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Figure 1. PN Ligands used a) imidazol-2-yl phosphanes R = H (1), Me (2), b) imidazol-4(5)-yl 
phosphanes R = iPr (3), Ph (4), tBu (5) {n = 2-0 (a-c)}, and c) 1-methylimidazol-4-
yldiphenylphosphane (6) and 1-methylimidazol-5-yldiphenylphosphane (7). 
In contrast to the well-elaborated procedures for the preparation of imidazol-2-ylphosphanes, 
syntheses of the isomeric imidazol-4-yl- and imidazol-5-ylphosphanes are only scarcely described.21 
The imidazol-2-ylphosphanes 1a,c, 2a,c, 3a-c, 6 and 7 were prepared according to literature 
procedures.22 For the imidazol-4(5)-ylphosphane ligands we adopted a protocol previously described 
by us starting from 2-organylimidazoles (Scheme 1).23 The 31P{1H} NMR spectroscopic data of 
synthesized ligands is summarized in Table 1 and the 31P{1H} NMR chemical shifts are typical for 
mono-, bis- and tris(imidazolyl)phosphanes. 
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Scheme 1. Reaction schemes for the syntheses of imidazol-4(5)-yl phosphanes 4-MIPR (R = iPr, Ph, 
tBu). 
PR3  +  [(tht)AuCl] (PR3)AuCl
–tht  
Scheme 2. Reaction scheme for the synthesis of complexes of the type (L)AuCl. 
The gold(I) phosphane complexes of the type [(L)AuCl] (L = imidazolyl phosphane ligand) are 
obtained as white solids in good yields by reaction of the corresponding ligand and [(tht)AuCl] in 
dichloromethane or methanol at room temperature (Scheme 2). The complex [(6)AuCl] was 
prepared in acetone as both the tris(imidazol-2-yl)phosphane ligands and the corresponding gold(I) 
complexes tend to decompose in protic solvents. The decomposition of all gold(I) complexes 
bearing imidazol-2-yl phosphane ligands was monitored by time dependent 1H NMR spectroscopy 
in methanol-d4 and D2O (see part catalyst deactivation pathways and ESI). All complexes were 
characterized by 1H and 31P{1H} NMR spectroscopy as well as MALDI and ESI mass spectrometry 
and elemental analysis (see ESI). The 31P{1H} NMR chemical shifts of the ligands and the resulting 
complexes (L)AuCl are summarized in Table 1. The 31P{1H} NMR spectra of the complexes show a 
substantial coordination shift of 35 to 57 ppm to lower field compared to the free ligands.  
Due to the ambidentate nature of the PN ligands, next to the usual linear (ĸP) coordination pattern 
of gold, dinuclear (ĸ2P,N) structures can result. Previously, solid state structures of the mononuclear 
complex [(3a)AuCl] and the dimeric structure [{(3c)Au}2]Cl2 have been reported by us.24 A 
coordination shift of ∆δ(31P) > 50 ppm is usually found for a bridging coordination mode of the PN 
ligand, whereas a shift of ca. 40 ppm is found in the mononuclear complexes. The MALDI MS 
spectra of all complexes (L)AuCl show the signal for the ion [(L)AuCl]+ as the basic peak and a 
further signal for the corresponding dimer [(L)2Au2Cl]+. 
 
 
Table 1. Spectroscopic data of the ligands and gold(I) complexes (∆δ = δC – δL).  
 Ligand δL(31P) δC(31P) ∆δ(31P
) 
 1a –22b 16b 38 
 5
 2a –28b 13a 41 
 3a –31b 14b 45 
MIPR 10 –25b 11a 36 
 11 –34a 11a 45 
 12 –29a 11a 40 
 4 –34 11c 45 
 5 –31a 12a 43 
 1b –46b –4b 42 
BIPR 2b –45b –4a 41 
 3b –58b –5b 53 
 1c –73c –20c 53 
TIPR 2c –59c –19c 40 
 3c –80b –23b 57 
[a] CDCl3, [b] MeOD-d4, [c] dmso-d6. 
Three component coupling reaction. Selected gold(I) complexes with PN ligands have been 
investigated as potential bifunctional catalysts in the synthesis of propargylamines by three 
component coupling of piperidine, benzaldehyde and phenyl acetylene (Scheme 3).  
First we investigated the catalytic activity of the selected gold(I) complexes under biphasic 
conditions, as especially the tris(imidazolyl)phosphane ligands are water-soluble. The catalytic trials 
were carried out in aqueous reaction mixtures under an atmosphere of N2 at 40 °C for 42 h using the 
procedure published by Elie et al.25 The results of the trials under biphasic conditions are 
summarized in Table 2. Complex (2b)AuCl shows the highest activity with a conversion of 75 % 
and a catalyst loading of only 0.5 mol% but when the catalyst loading was increased to 5 mol% even 
conversion by complex (2c)AuCl raised from 65 to 97 %. It has to be mentioned that the complexes 
(L)AuCl of ligands 2a, 2b, 3a and 3b, did not dissolve completely under the conditions used for the 
biphasic catalysis (at 0.5 mol%). 
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Scheme 3. Three component coupling of benzaldehyde, piperidine and phenylacetylene catalyzed by 
gold(I) complexes. 
Table 2. Catalytic trials of complexes (L)AuCl in the three-component coupling of phenylacetylene, 
benzaldehyde and piperidine under biphasic conditions (conversion determined by 1H NMR 
spectroscopy, given in mean ± error). 
Entry Ligand Catalyst loading [mol %] Conversion [%] 
1 2-MIPNMe (2a) 0.5 63 ± 1 
2 2-BIPNMe (2b) 0.5 75 ± 5 
3 2-TIPNMe (2c) 0.5 65 ± 3 
4 2-TIPNMe (2c) 5 97 ± 1 
5 4-MIPiPr (3a) 0.5 16 ± 1 
6 4-BIPiPr (3b) 0.5 40 ± 2 
7 4-TIPiPr (3c) 0.5 37 ± 3 
 
When the gold(I) complexes were used in the neat mixture of the organic reactants the catalytic 
trials could be carried out under homogenous conditions (40 °C, 42 h). The results obtained by the 
so modified protocol are summarized in Table 3. The conversions are considerably higher compared 
to the results obtained under aqueous biphasic conditions. 
Table 3. Screening of catalysts (L)AuCl in the three components coupling of phenyl acetylene, 
benzaldehyde and piperidine under homogenous conditions. Na[(TPPMS)AuCl], 
Na2[(TPPDS)AuCl], Na3[(TPPTS)AuCl] and [(Ph3P)AuCl] as reference compound (conversion 
determined by 1H NMR spectroscopy, given in mean ± error). 
Entry Ligand Catalyst loading [mol %] Conversion [%] 
1 2-MIPNMe (2a) 0.5 70 ± 2 
2 4-MIPNMe (6) 0.5 61 ± 3 
3 5-MIPNMe (7) 0.5 92 ± 1 
4 2-BIPNMe (2b) 0.5 82 ± 2 
5 2-TIPNMe (2c) 0.5 95 ± 2 
6 2-TIPNMe (2c) 5 98 ± 1 
7 2-MIPH (1a) 0.5 46 ± 1 
8 2-BIPH (1b) 0.5 74 ± 2 
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9 2-TIPH (1c) 0.5 87 ± 1 
10 4-MIPiPr (3a) 0.5 26 ± 2 
11 4-BIPiPr (3b) 0.5 35 ± 4 
12 4-TIPiPr (3c) 0.5 74 ± 1 
13 4-MIPtBu (5) 0.5 67 ± 2 
14 TPPMS 0.5 25 ± 1 
15 TPPDS 0.5 32 ± 5 
16 TPPTS 0.5 39 ± 4 
17 Ph3P 0.5 26 ± 3 
 
It is obvious that the connectivity (2-, 4- or 5-yl) as well as the substitution pattern of the 
imidazolyl substituents in the PN ligands show an effect on the catalytic activity of their gold(I) 
complexes. The catalytic activity of the complexes increases within every series in the order MIP < 
BIP < TIP. Within the series, the complexes with the N-methylated ligands 2a-c show the highest 
activity. Complex (2c)AuCl shows the highest conversion of 95 % at a catalyst loading of 0.5 mol%. 
Here, the conversion is as high as under biphasic conditions using the tenfold higher catalyst 
loading. 
Within the series of the complexes (L)AuCl with the isomeric ligands 2-MIPNMe (2a), 4-MIPNMe 
(6) and 5-MIPNMe (7) (entries 1-3), (2a)AuCl and (6)AuCl exhibit about the same conversion (70 and 
61 %, respectively), whereas (7)AuCl shows a conversion of 92 %. All complexes, with exception of 
(3a)AuCl (entry 10), show higher catalytic activity then the reference compounds (entries 14-17). 
Markovnikov hydration of terminal alkynes. Since gold(I) complexes with pyridylphosphane 
ligands have been shown to convert 1-pentyne to 2-pentanone in very high yields,20 the catalytic 
activity of our gold(I) imidazolylphosphane complexes in the hydration of terminal alkynes was 
investigated as well (Scheme 4). The respective gold(I) complex (5 mol% in regard to the alkyne) 
was dissolved in degassed acetone, the chloride abstracted in situ by addition of one equivalent 
AgOTf. 1-Ocytne and water (10 eq. in regard to the alkyne) were added to the solution, which was 
then stirred at 60 °C. The results of the catalytic trials are summarized in Table 4. 
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Scheme 4. Markovnikov hydration of alkynes. 
Table 4. Preformed gold complexes and their catalytic activity after halide abstraction in situ using 
AgOTf in acetone.  
Entry Catalyst Conversiona [% (h)] 
1 (1a)AuCl 6 (22) 
2 (2a)AuCl 30 (22) 
3 (2b)AuCl 5 (22) 
4 (2c)AuCl 0 (22) 
5 (6)AuCl 17 (22) 
6 (3a)AuCl 2 (22) 
7 (3b)AuCl 0 (22) 
8 [{(3c)Au}2]Cl2 0 (22) 
9 [{(3c)Au}2{AuCl}2]Cl2 1 (22) 
10 [{(5)Au}2AuCl2]Cl 60 (22) 
11 (4)AuCl 61 (22), 93 (48) 
12 [(PPh3)AuCl] 95 (22) 
[a] conversion to 2-octanone. 
While gold complexes with bis(imidazolyl)phosphanes as well as tris(imidazolyl)phosphanes of 
any kind proved inactive, complexes with mono(imidazolyl)phosphanes show catalytic activity 
towards the hydration of 1-octyne. The most active gold(I) imidazolyl complexes are 
[{(5)Au}2AuCl2]Cl and [(4)AuCl]  with 60 % and 61 % conversion of 1-octyne to 2-octanone within 
22 h respectively. N-Methylated imidazol-2-yl ligands show a higher conversion rate than ligands 
containing a NH-function and ligands possessing large substituents in the position adjacent to the 
nitrogen show the highest conversion rates (entries 1-4).  
Interestingly, the triphenylphosphane gold(I) complex [(PPh3)AuCl] shows the highest activity in 
the conversion of 1-octyne to 2-octanone (entry 12). Complexes of the type [(PPh3)Au(CH3)] have 
already been shown to be good catalysts in the hydration of alkynes in the presence of acid co-
catalysts. The thus generated [(PPh3)Au]+ is active in many reactions involving triple bonds,26 one of 
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them being the addition of methanol across a triple bond. However, [(PPh3)AuCl] has not been 
mentioned as catalyst for the hydration of terminal alkynes before. 
Catalyst deactivation pathways. A major problem of multifunctional ligands in catalytic 
applications is the elucidation of the structure of the actually active species. In the case of gold(I) 
complexes of PN ligands, e.g. imidazolyl phosphanes, it is hard to define which species is the 
catalytic active species and which species are present in solution. Different coordination modes as 
κP- or κN-monodentate, κ2PN-chelating, μ-PN bridging as well as polynuclear species with 
combination of these binding modes can be formed. Complexes bearing Au2, Au3 and Au4 units 
have been observed with different imidazolyl phosphane ligands before.27  From the reaction mixture 
of trial 12, Table 3, we obtained a crystal of [(5)2Au3Cl2]Cl whose structure could be determined by 
x-ray diffraction (Figure 2). Such polynuclear complexes can be prepared directed by reaction of the 
PN ligands with [(tht)AuCl] in the corresponding stoichiometry (Scheme 5). This has been 
demonstrated by the formation of complexes [(L)2Au3Cl2]Cl (L = 3c, 5) and complex 
[(3c)2Au4Cl2]Cl2 (Figure 3). The Aun complexes (n = 2-4) of the PN ligands show coordination 
shifts of ∆δ(31P) > 50 ppm which is typical for a bridging coordination mode of the PN ligand, as 
stated before. The polynuclear structure of these complexes is seen by the characteristic signals of 
the molecular ions in the MALDI-TOF spectra. 
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Scheme 5. Synthesis of polynuclear complexes Aun stabilized by PN ligands. 
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Figure 2. Molecular structure of [(5)2Au3Cl2]Cl, ellipsoids at 30 % probability. Hydrogen atoms, 
solvent molecules, and non-coordinated chloride anions were omitted for clarity. Selected bond 
lengths [Å] and angles [°]:Au1-Au2  3.1863(4), Au1-Au3 3.3075(4), Au2-Au3 3.1043(4), Au2-N2 
2.013(5), Au2-N32 2.017(6), Au1-P1 2.236(2), Au1-Cl1 2.290(2), Au3-P31 2.232(2), Au3-Cl31 
2.294(2), Au1-Au2-Au3 63.427(9), Au1-Au3-Au2 59.495(9), Au2-Au1-Au3 57.078(9), N2-Au2-
N32 176.0(2), P1-Au1-Cl1 175.24(7), P31-Au3-Cl31 173.55(8). 
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Figure 3. Molecular structure of [(3c)2Au4Cl2]Cl2, ellipsoids at 30 % probability. Hydrogen atoms 
and non-coordinated chloride anions were omitted for clarity. Selected bond lengths [Å] and angles 
[°]: Au1-Au2  3.0695(4), Au1-Au2#1  3.1102(4), Au1-P1  2.2258(19), Au1-Cl1  2.2848(19), Au2-
N18  2.019(6), Au2-N2  2.023(6), P1-Au1-Cl1  176.73(7), N2-Au2-N18  174.1(2), Au1-Au2-Au1  
94.246(10), Au2-Au1-Au2 85.754(10). 
Based on the results of the catalytic trials under biphasic conditions and further stability studies, 
we observed that gold(I) complexes of imidazol-2-ylphosphane ligands are unstable in protic 
solvents, especially complexes (1c)AuCl and (2c)AuCl. In water and methanol solvolysis of the P–C 
bond and therefore decomposition of the gold complexes yields H3PO3 and P(OCH3)3, respectively, 
imidazole and the corresponding bis(NHC) gold(I) complexes [(C3H4N2)2Au]+ (C6) and 
[(C4H5N2)2Au]+ (C3), respectively (Scheme 6).  
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Scheme 6. Formation of gold(I) bis(NHC) complexes. 
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The formation of complex C6 is completed within one hour. Complex (2c)AuCl is more stable and 
the corresponding bis(NHC) complex C3 is formed within 20 hours. The bis(NHC) gold(I) 
complexes were identified by MALDI TOF MS, 1H and 13C{1H} NMR spectroscopy. The NMR 
signals were identified unambiguously by adding samples of the independently prepared bis(NHC)s 
gold (I) complexes [(C3H4N2)2Au]Cl28 (C6) and [(C4H6N2)2Au]Cl29 (C3) to the corresponding 
reaction mixtures. Both bis(NHC) complexes C3 and C6 were tested for their catalytic activity and 
show no activity in the three component coupling reaction nor in the hydration of terminal alkynes. 
The stability of imidazol-2-yl phosphane gold(I) complexes towards solvolysis depends on the 
number of hetero aryl substituents on the phosphorus atom. While the tris(imidazol-2-yl)phosphane 
complexes (1c)AuCl and (2c)AuCl decompose within minutes to the respective bis(NHC) gold(I) 
complexes, the corresponding BIP and MIP complexes are much more stable in protic solvents. This 
is in accord with the observed activity of the corresponding complexes in the three component 
coupling reaction under biphasic and homogenous conditions (Table 2 and 3). In contrast to the 
gold(I) complexes of imidazol-2-ylphosphane ligands, the isomeric compounds containing the P–C 
bond in C4- or C5-position of the imidazolyl substituent are stable in protic solvents and do not 
decompose even after prolonged time. 
Very recently, Chauvin et al. reported on the formation of NHC complexes from 
imidazolylphosphane complexes by P–C bond cleavage.30 Here too, the reactivity of the imidazol-2-
ylphosphane ligands resembles the reactivity of imidazolylphosphanes after protonation of the imine 
N atom, (Scheme 7). 
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Scheme 7. Protonation of imidazol-2-phosphanes give imidazolylphosphanes. 
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Conclusion 
We have screened series of imidazole-based PN ligands in the gold(I) catalyzed three component 
coupling of aldehydes, amines and terminal alkynes as well as in the Markovnikov hydration of 
terminal alkynes. In homogenous solution the conversions to the respective propargylamine was 
considerably higher than under biphasic conditions. Complex [(2c)AuCl] shows the highest 
conversion of 95 % with a catalyst loading of only 0.5 mol%. Under biphasic conditions a tenfold 
higher catalyst loading has to be used for high activity, which is due to decomposition of the gold(I) 
complexes to the corresponding bis(NHC) gold(I) complexes. Without any solvent the conversion 
rates using (2a)AuCl and (2b)AuCl are slightly higher (7%). The conversion using (2c)AuCl is with 
30 % considerably higher. Based on the results we distinguished that connectivity of the imidazolyl 
substituents to the phosphorous atom, their substitution pattern as well as the number of 
heteroaromatic substituents have important effects on the catalytic activity of these gold(I) 
complexes. 
In the Markovnikov hydration of 1-octyne the gold(I) complexes showed activities below or in the 
magnitude of [(Ph3P)AuCl]. Here the catalytic activity of complexes within the imidazol-4-yl 
phosphane series increases with increase in steric bulk of the substituent (t-Bu > Ph > i-Pr) at the 
C2-position, which has been reported for pyridyl-based PN ligands. 
 The imidazole-based PN ligands can display various coordination modes in their gold(I) 
complexes. Depending on the ligand-to-metal ratio polymetallic complexes with Au2, Au3 and Au4 
units can be formed. A unique feature of imidazol-2-yl phosphanes within the isomeric imidazol-2-
yl, 4-yl- and -5yl phosphanes is their sensitivity towards P–C bond cleavage in protic solvents. This 
reactivity resembles the NHC-phosphenium adduct nature of imidazol-2-yl phosphanes after 
protonation. In the corresponding gold(I) complexes this reaction results in the formation of 
catalytically inactive bis(NHC)-gold(I) complexes with imidazol-2-yl phosphane ligands as well as 
the formation of polynuclear species with imidazol-4(5)-yl phosphane ligands. 
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Experimental Section 
The procedures for the preparation of ligands 4-MIPPh (4) and 4-MIPtBu (5) and complexes 
(L)AuCl, as well as the corresponding NMR and MS data and elemental analyses can be found in 
the supporting information. The compounds [(tht)AuCl], 1- methyl-2-trimethylsilylimidazole, 2-
MIPH (1a), 2-TIPH (1c), ), 4-BIPiPr (3b), 4-MIPNMe (4), 5-MIPNMe (5) as well as the gold(I) 
complexes (2a)AuCl, (2b)AuCl, (2c)AuCl, [(3a)AuCl], [(3c)2Au2]Cl2, Na[(tppms)AuCl], 
Na2[(tppds)AuCl] and Na3[(tppts)AuCl] were prepared according literature procedures. The 
preparations were carried out in Schlenk tubes under an atmosphere of dry nitrogen using anhydrous 
solvents purified according to standard procedures. The metal complexes were prepared using wet 
solvents. All chemicals were used as purchased. 1H and 31P{1H} NMR spectra were recorded on a 
Bruker DRX 200 and 13C{1H} NMR spectra on a Bruker DRX 500 spectrometer. The 1H and 
13C{1H} NMR spectra were calibrated against the residual proton signals and the carbon signals of 
the solvents as internal references (chloroform-d: δH = 7.30 ppm and δC = 77.0 ppm; methanol-d4: δH 
= 3.31 ppm and δC = 49.1 ppm, dmso-d6: δH = 2.50 ppm and δC = 39.5 ppm; D2O: δH = 4.79) while 
the 31P{1H} NMR spectra were referenced to external 85 % H3PO4. The MALDI mass spectra were 
recorded on a Bruker Ultraflex MALDI-TOF mass spectrometer and ESI mass spectra with a 
Finnigan LCQ Deca Ion-Trap-API mass spectrometer. The elemental composition of the compounds 
was determined with a Perkin Elmer Analysator 2400 at the Institut für Pharmazeutische und 
Medizinische Chemie, Heinrich-Heine-Universitat Dusseldorf. 
 
Crystallographic data were collected at 183(2) K on an Oxford Diffraction Xcalibur system with a 
Ruby detector using Mo Kα radiation (λ = 0.7107 Å) that was graphite-monochromated. Suitable 
crystals were covered with oil (Infineum V8512, formerly known as Paratone N), mounted on top of 
a glass fibre and immediately transferred to the diffractometer. The program suite CrysAlisPro was 
used for data collection, multi-scan absorption correction and data reduction.31 Structures were 
solved with direct methods using SIR9732 and were refined by full-matrix least-squares methods on 
F2 with SHELXL-97.33 The structures were checked for higher symmetry with help of the program 
Platon.34 The structure of [(5)2Au3Cl2]Cl contained five chloroform molecules out of which three are 
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half occupied. Two of these three chloroform molecules are sitting on special positions. Remaining 
residual electronic density caused by disordered solvent molecules was treated with the program 
utility SQUEEZE of the Platon program suite.34 Suitable restraints were applied. The cif files can be 
found in the supporting information. Additionally, CCDC 816459 and 816460 contain the 
supplementary crystallographic data for this paper. These data can be obtained free of charge from 
The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.  
 
 [(5)2Au3Cl3]: A dichloromethane solution (10 mL) of 4-MIPtBu (5) (77 mg, 0.25 mmol) and 
[(tht)AuCl] (120 mg, 0.374 mmol) were stirred for 4 h at ambient temperature. The solution was 
concentrated in vacuo to 1/10th and the product precipitated by addition of diethyl ether. Yield: 0.11 
g (68 %). 1H NMR (200 MHz, 296 K, CDCl3): δ = 1.40 (s, 18H, CH3), 6.83 (s, 2H, Him), 7.62 – 7.73 
(m, 20H, HPh), 13.52 (br, 2H, NH). 31P{1H}-NMR (81 MHz, 296 K, CDCl3): δ = 18 (s). MALDI 
TOF (DIT, CHCl3): m/z = 541 [LAuCl]+, 1277 [L2Au3Cl2]+. C38H42N4P2Au3Cl3·2 C4H10O (1462.23): 
calc. C 37.79, H 4.27, N 3.83; found C 37.8, H 4.2, N 3.8. 
[(3c)2Au4Cl4]: A dichloromethane solution (10 mL) of 4-TIPiPr (3c) (70 mg, 0.19 mmol) and 
[(tht)AuCl] (128 mg, 0.399 mmol) were stirred for 17 h at ambient temperature. All volatiles were 
removed in vacuo, the oily residue dissolved in dichloromethane (2 mL) and the product precipitated 
by addition of diethyl ether. Yield: 0.11 g (67 %). 1H NMR (200 MHz, 296 K, MeOD-d4): δ = 1.36-
1.50 (m, 36H, CH(CH3)2), 3.15 (sept, 3JHH = 6.85 Hz, 2H, CH(CH3)2(free)), 3.66 (sept, 3JHH = 7 Hz, 
4H, CH(CH3)2(coord.)), 7.66 (s, 2H, Him(free)), 7.72 (s, 4H, Him(coord.)). 31P{1H} NMR (81 MHz, 296 K, 
MeOD-d4): δ = –14 (s). ESI+ (CH3OH): m/z = 556 [LAu]+, 1110 [L2Au2-H]+, 1306 [L2Au3-2H]. 
MALDI TOF (DIT, CHCl3): m/z = 591 [LAuCl+H]+, 913 [L2Au]+, 11109 [L2Au2-H]+, 1305 [L2Au3-
2H]+. C36H54N12P2Au4Cl2·½ C4H10O (1611.19): calc. C 28.30, H 3.69, N 10.42; found C 28.3, H 4.2, 
N 10.9. 
Gold-Catalyzed Three-Component Coupling Reactions: In a Schlenk tube, under N2, the 
appropriate amount of the catalyst was weight and phenyl acetylene (160 µL, 1.60 mmol), 
benzaldehyde (100 µL, 1.00 mmol), and piperidine (110 µL, 1.10 mmol) were added. Without 
purification the reaction mixture was analyzed by 1H NMR spectroscopy. 
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Catalytic Hydration Reactions: Method a) Halide abstraction in situ: The gold complex (0.01 
mmol, 5 mol% catalyst loading) was dissolved in acetone (0.4 mL) and a solution of AgOTf (1 eq.) 
in acetone (0.1 mL) is added. A white precipitate formed and the solution turned yellow. Degassed 
1-octyne (30 µL) and water (18 µL) were added and the reaction mixture stirred at 60 °C in an oil 
bath. The progress of the reaction was monitored via GC. Method b) The gold chlorido compound 
was dissolved in dichloromethane and a solution of AgOTf (1 eq.) in dichloromethane was added. 
The mixture was stirred in a dark Schlenk tube at room temperature for 1 h and precipitated AgCl 
was filtered off. Removal of most of the solvent under vacuum and addition of diethyl ether resulted 
in the respective gold complex as a fine white powder, which was dried in vacuo. The so obtained 
gold compound (0.01 mmol, 5 mol% catalyst loading) was dissolved in acetone (0.4 mL) and 
degassed 1-octyne (30 µL) and water (18 µL) were added to the solution. The reaction mixture was 
stirred at 60 °C in an oil bath. The progress of the reaction was monitored via GC.  
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Supporting Experimental Information 
 
 
 
Figure ESI : NMR spectra of the decomposition of (2c)AuCl 
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Table ESI1.  Crystal data and structure refinement for [(5)2Au3Cl2]Cl·3.5CHCl3 and [(3c)2Au4Cl2]Cl2. 
 [(5)2Au3Cl2]Cl·3.5CHCl3 [(3c)2Au4Cl2]Cl2 
Empirical formula  C41.5H45.5Au3Cl13.5N4P2 C36H54Au4Cl4N12P2 
Formula weight  1731.73 1646.52 
Crystal system  Orthorhombic Monoclinic 
Space group  Pnma P21/n 
a [Å]  21.7709(5)  13.3045(3)  
b [Å]  52.9615(10)  10.48360(17)  
c [Å]  10.8215(3)  19.0693(3)  
 [°]  90 101.1250(18) 
Volume [Å3]  12477.4(5)  2609.79(8)  
Z 8 2 
Density (calculated) [Mg/m3]  1.844  2.095  
Absorption coefficient [mm-1]  7.698 11.512 
Crystal size [mm3]  0.28 x 0.10 x 0.05  0.18 x 0.12 x 0.03  
Crystal description colourless plate colourless plate 
Reflections collected 45556 15143 
Independent reflections 15637 [R(int) = 0.0426] 6470 [R(int) = 0.0330] 
Reflections observed 9849 4685 
Completeness to theta  99.9 % to 28.28°  99.9 % to 28.28°  
Data / restraints / parameters 15637 / 10 / 624 6470 / 61 / 275 
Goodness-of-fit on F2 0.933 1.001 
Final R indices [I>2sigma(I)] R1 = 0.0416, wR2 = 0.1005 R1 = 0.0399, wR2 = 0.0914 
R indices (all data) R1 = 0.0785, wR2 = 0.1064 R1 = 0.0638, wR2 = 0.0962 
Largest diff. peak and hole [e.Å-3]  1.253 and -1.585 2.491 and -1.096 
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Bisimidazol-2-ylphenyl phosphane, (2-BIPH, 1b): A solution of n-butyl lithium in n-hexane (1.6 M, 
12 mL, 19 mmol) was added drop-wise to a solution of 3.0 g (18 mmol) of 1-
diethoxymethylimidazole in diethyl ether (150 mL) at –78°C. The reaction mixture was stirred at –
40°C for 1 h and then was cooled to –78°C and PCl3 (1.56 g, 8.72 mmol) was added. The reaction 
mixture was stirred at –78°C for 1h and at ambient temperature over night. Concentrated ammonia 
solution (5 mL) was added, the phases separated, the organic phase was collected and all volatiles 
were removed in vacuo. The oily residue was dissolved in 100 mL acetone/water (10:1) and stirred 
at ambient temperature for 72 h. The resulting precipitate was collected by filtration and dried in 
vacuo. Yield: 1.1 g (52 %). 1H NMR (MeOD-d4): δ = 7.27 – 7.35 (m, 9H). 31P{1H} NMR (MeOD-
d4): δ  = –46 (s). ESI+ (CH3OH): m/z (%) = 243 [L]+. C12H11N4P·CH3OH (274.26): calc. C 56.93, H 
5.51, N 20.43; found C 56.4, H 5.6, N 20.7.  
2-Phenylimidazol-4(5)-yldiphenyl phosphane (4-MIPPh, 4): 1-Methoxymethyl-2-phenylimidazole 
(1.5 g, 8.0 mmol) is placed in a Schlenk tube equipped with a magnetic stirring bar and dissolved in 
dry thf (100 mL). At –78 °C tert-butyllithium (5.3 mL, 1.6 M in hexane) is added slowly to the 
solution, which turns deep red. The reaction mixture is stirred at –78 °C for 1 h until the 
diphenylchlorophosphane (1.6 mL, 8.0 mmol) is slowly added to the solution, which turns yellow 
and is then stirred over night at room temperature. The solvent is removed and the residue is 
dissolved in with ammonia-saturated dichloromethane. This solution is stirred over night and the 
white solid is filtered off. The solvent is removed from the filtrate and the residue dissolved in 
acetone/water (10 : 1) and 2 mL of conc. Hydrochloric acid added. The mixture is refluxed for 4 
hours, all volatiles removed in vacuo and the residue dissolved in a minimum amount of ethanol and 
sodium hydroxide solution added. The precipitate is filtered off, washed with diethyl ether and dried 
in vacuo. Yield: 1.39 g (53 %). 1H NMR (200 MHz, CDCl3): δ = 3.23 (s, 3H, OCH3), 5.40 (d, J = 
1.5 Hz, CH2), 6.86 Hz (s, Him), 7.33–7.85 (m, 15H, Ph). 31P{1H} NMR (81 MHz, CDCl3): δ = –34.0. 
ESI MS (methanol): m/z (rel. int.) = 386 (100) [M+NaCl]+, 329 (15) [M+H]+. C21H17N2P·C2H5OH 
(374.42): calc. C 73.78, H, 6.19, N 7.48; found C 73.85, H 5.50, N 7.02. 
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2-tert-Butylimidazol-4(5)-yldiphenyl phosphane (4-MIPtBu, 5): 1-Methoxymethyl-2-tert-
butylimidazole (1.3 g, 8.0 mmol) is placed in a Schlenk tube equipped with a magnetic stirring bar 
and dissolved in dry thf (100 mL). At –78 °C tert-butyllithium (5.3 mL, 1.6 M in hexane) is added 
slowly to the solution, which turns deep red. The reaction mixture is stirred at –78 °C for 1 h until 
the diphenylchlorophosphane (1.6 mL, 8.0 mmol) is slowly added to the solution, which turns 
yellow and is then stirred over night at room temperature. The solvent is removed and the residue is 
dissolved in with ammonia-saturated dichloromethane. This solution is stirred over night and the 
white solid is filtered off. The solvent is removed from the filtrate and the residue dissolved in 
acetone/water (10 : 1) and 2 mL of conc. hydrochloric acid added. The mixture is refluxed for 4 
hours, all volatiles removed in vacuo and the residue dissolved in a minimum amount of ethanol and 
sodium hydroxide solution added. The precipitate is filtered off, washed with diethyl ether and dried 
in vacuo. Yield: 1.06 g (43 %). 1H NMR (200 MHz, CDCl3): δ = 1.34 (s, 9H, CH3), 6.91 Hz (s, Him), 
7.25–7.35 (m, 10H, Ph). 31P{1H} NMR (81 MHz, CDCl3): δ = –31.0. ESI+ (methanol): m/z (%) = 
309 [M+H]+ (100), 249 [M-tBu]+ (95). C19H21N2P·5/3H2O (308.36): calc. C 67.44, H, 7.23, N 8.27; 
found C 67.49, H 6.90, N 8.14. 
General procedure for the synthesis of gold(I) complexes (L)AuCl: To a stirred solution of 
(tht)AuCl was added the ligand solution in a convenient solvent. The reaction solution was stirred 
for at least 4 h at room temperature. The resulting solution was concentrated in vacuo and diethyl 
ether was layered to precipitate white powders. The product precipitate was filtered and dried in 
vacuo.   
(2-MIPH)AuCl, (1a)AuCl: A solution of (tht)AuCl (80 mg, 0.25 mmol) in CH2Cl2 (5 mL) was 
added to a stirred solution of 2-MIPH (63 mg, 0.25 mmol) in CH3OH (5 mL). Yield: 98 mg (81 %). 
1H NMR (MeOD-d4): δ = 7.51-7.66 (m, 12H, HPh/im). 31P{1H} NMR (MeOD-d4): δ = 16 (s). ESI+ 
(CH3OH): m/z (%) = 898 [(LAuCl)2]+. MALDI MS (CH3OH): m/z (%) = 485 [LAuCl]+, 897 
[(LAuCl)2]+. EI MS (Pt, 180°C): m/z (%) = 251 [L]+, 484 [LAu]+, 895 [L2Au2-2H]+. 
C15H13N2PAuCl·½CH2Cl2 (527.14): calc. C 35.32, H 2.68, N 5.31; found C 35.4, H 2.4, N 5.1. 
 24
(2-BIPH)AuCl, (1b)AuCl: A solution of (tht)AuCl (100 mg, 0.31 mmol) in CH2Cl2 (5 mL) was 
added to a stirred solution of 2-BIPH (76 mg, 0.31 mmol) in CH3OH (10 mL). Yield: 0.11 g (74 %). 
1H NMR (MeOD-d4): δ = 7.51 – 7.73 (m, 9H, Him/Ph). 31P{1H} NMR (MeOD-d4): δ = –4 (s). ESI+ 
(CH3OH): m/z (%) = 475 [LAuCl]+, 877 [(LAu)2]+. MALDI MS (CH3OH): m/z (%) = 440 [LAu]+, 
878[(LAu)2]+. C12H11N4PAuCl·¼CH2Cl2 (495.87): calc. C 29.67, H 2.34, N 11.30; found C 30.1, H 
2.7, N 10.9.  
(2-TIPH)AuCl, (1c)AuCl: A solution of (tht)AuCl (61 mg, 0.19 mmol) in CH2Cl2 (5 mL) was added 
to a stirred suspension of 2-TIPH (44 mg, 0.19 mmol) in acetone (15 mL). The mixture was stirred 
for 72 h and the resulting precipitate was filtered, washed with diethylether and dried under vacuo. 
Yield : 64 mg (73 %). 1H NMR (dmso-d6): δ = 7.41 (s, 6H, Him), 13.24 (br, NH). 31P{1H} NMR 
(dmso-d6): δ = –20 (s). MALDI MS (CH3OH): m/z (%) = 333 [(C3H4N2)Au]+, 465 [LAuCl]+. 
C9H9N6PAuCl·½ CH2Cl2 (507.07): calc. C 22.50, H 1.99, N 16.57; found C 22.1, H 1.8, N 16.3. 
(4-BIPiPr)AuCl, (3b)AuCl: A solution of (tht)AuCl (60 mg, 0.19 mmol) in CH2Cl2 (5 mL) was 
added to a stirred solution of 4-BIPiPr (61 mg, 0.19 mmol) in CH3OH (5 mL). Yield: 93 mg (88 %). 
1H NMR (MeOD-d4): δ = 1.37 (d, J = 6.89 Hz, 12H, CH(CH3)2), 3.18 – 3.28 (sept, 2 H, H2), 7.52 – 
7.80 (m, 7H, HPh/im). 31P{1H} NMR (MeOD-d4): δ = –5 (br). ESI+ (CH3OH): m/z (%) = 524 [LAu]+, 
1046 [(LAu)2]+. MALDI MS (CH3OH): m/z (%) = 559 [LAuCl]+, 1045 [(LAu)2]+, 1081 [(LAu)2Cl]+. 
C18H23N4PAuCl (558.80): calc. C: 38.69, H 4.15, N 10.03; found C: 38.9, H 3.9, N 10.3. 
(4-MIPNMe)AuCl, (6)AuCl: A solution of (tht)AuCl (96 mg, 0.3 mmol) in CH2Cl2 (5 mL) was 
added to a stirred solution of 4-MIPNMe (80 mg, 0.3 mmol) in CH2Cl2 (5 mL). Yield: 99 mg (66 %). 
1H NMR (CDCl3): δ = 3.73 (s, 3H, NCH3), 7.35 – 7,78 (m, 7H, HPh/im).  31P{1H} NMR (CDCl3): δ = 
11 (s). MALDI MS (CH3OH): m/z (%) = 463 [LAu]+, 499 [LAuCl], 729 [L2Au]+, 961 [L2Au2Cl]+, 
1193 [L2Au3Cl2]+. C16H15N2PAuCl·½ CH2Cl2·¼ C4H10O (559.70): calc. C 37.55, H 3.33, N 5.01; 
found C 37.6, H 3.2, N 4.6. 
(5-MIPNMe)AuCl, (7)AuCl: A solution of (tht)AuCl (100 mg, 0.31 mmol) in CH2Cl2 (5 mL) was 
added to a stirred solution of 5-MIPNMe (83 mg, 0.31 mmol) in CH2Cl2 (5 mL). Yield: 90 mg (58 %). 
1H NMR (CDCl3): δ = 3.81 (s, 3H, NCH3), 6.73 (br, 1H, Him), 7.55 – 7.73 (m, 10H, Hph), 7.79 (s, 
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1H, Him). 31P{1H} NMR (dmso-d6): δ = 11 (s). MALDI MS (CH3OH): m/z (%) = 499 [LAuCl]+. 
C16H15N2PAuCl·1.5 CHCl3·1 H2O (695.77): calc. C 30.21, H 2.68, N 4.03; found C 29.8, H 2.8, N 
4.4.  
 (4-MIPPh)AuCl, (4)AuCl: A solution of (tht)AuCl (20 mg, 0.062 mmol) in CH2Cl2 (2 mL) was 
added to a stirred solution of 4-MIPPh (20 mg, 0.062 mmol) in CH2Cl2 (2 mL). Yield: 32 mg (93 %). 
1H NMR (dmso-d6): δ = 7.43-8.14 (m, 16H, Ph+CH); 31P{1H}-NMR (dmso-d6): δ = 11 (s). MALDI 
MS (CH3OH): m/z = 1317 [Au3L2Cl2]+, 1085 [Au2L2Cl]+, 560 [AuLCl]+, 524 [AuL]+. 
C21H17N2P1AuCl (560.77): calc. C 41.92, H 2.97, N 4.33; found C 41.90, H 3.27, N 3.95. 
(4-MIPtBu)AuCl, (5)AuCl: A solution of (tht)AuCl (20 mg, 0.062 mmol) in CH2Cl2 (2 mL) was 
added to a stirred solution of 4-MIPPh (19 mg, 0.062 mmol) in CH2Cl2 (2 mL). Yield: 28 mg (89 %). 
1H NMR (dmso-d6): δ = 1.32 (s, 9H, CH3), 7.56-7.75 (m, 11H, Ph + CH), 12.58 (bs, 1H, NH). 
31P{1H} NMR (dmso-d6): δ = 11 (s). MALDI MS (CH3OH): m/z = 1277 [Au3L2Cl2]+, 1241 
[Au3L2Cl]+, 540 [AuLCl]+. C19H21N2PAuCl·1.5CH2Cl2 (668.18): calc. C 36.85 %; H 3.62 %; N 4.19 
%; found C 36.7 % H 3.7 % N 3.7 %. 
                                                 
 
